Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Teodora Karan-Đurašević"'
Autor:
Vladimir Gašić, Zlatko Pravdic, Nada Suvajdzic, Irena Marjanovic, Teodora Karan-Đurašević, Sonja Pavlović, Nataša Tošić
Publikováno v:
HemaSphere, Vol 7, p e768020b (2023)
Externí odkaz:
https://doaj.org/article/b9dfddadb7f34637bfe15b75a51701ff
Autor:
Teodora Karan-Đurašević, Milena Ugrin, Vojin Vukovic, Darko Antic, Sanja Stankovic, Irena Marjanovic, Tatjana Kostic, Vladimir Otasevic, Kristina Tomic, Sofija Sarac, Biljana Mihaljevic, Sonja Pavlovic, Nataša Tošić
Publikováno v:
HemaSphere, Vol 7, p e1785725 (2023)
Externí odkaz:
https://doaj.org/article/90568f52a111473e8ba1a3e6a1614c67
Autor:
Vojin Vukovic, Teodora Karan-Đurašević, Pavle Tulic, Darko Antic, Vladimir Otasevic, Sofija Sarac, Andrej Pesic, Biljana Mihaljevic
Publikováno v:
HemaSphere, Vol 7, p e273137e (2023)
Externí odkaz:
https://doaj.org/article/43438f8bac42496a8e9699a82ba1b38a
Clinical significance of TP53 aberrations and IGHV mutational status in chronic lymphocytic leukemia
Publikováno v:
Medicinski Podmladak, Vol 71, Iss 4, Pp 47-53 (2020)
Chronic lymphocytic leukemia (CLL) is a very heterogeneous disease with a variable clinical course. On the one side of the spectrum, there are patients with aggressive and resistant disease, of which they die only a few months after diagnosis while,
Autor:
Dragana Janic, Nada Suvajdžić Vuković, Sonja Pavlovic, Predrag Rodic, Zorica Sumarac, Milan Lakocevic, Teodora Karan Đurašević, Tatjana Kostic, Milan Petakov
Publikováno v:
Journal of Medical Biochemistry, Vol 37, Iss 3, Pp 307-312 (2018)
Journal of Medical Biochemistry (2018) 37(3):307-312
Journal of Medical Biochemistry
Journal of Medical Biochemistry (2018) 37(3):307-312
Journal of Medical Biochemistry
Several studies support the evidence of increased incidence of hematological complications in Gaucher disease including monoclonal and polyclonal gammopathies and blood malignancies, especially multiple myeloma.Serum concentrations of immunoglobulins
Autor:
Teodora Karan-Đurašević
Publikováno v:
Универзитет у Београду
Hronična limfocitna leukemija (HLL), najčešći tip leukemije u Evropi i Severnoj Americi, se manifestuje kao klonska ekspanzija zrelih CD5+ CD19+ CD23+ sIgM+/- B limfocita i karakteriše se izuzetno heterogenim kliničkim tokom. Leukemični, kao i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b88352a5db8a51cf1892532aecb761
http://nardus.mpn.gov.rs/bitstream/id/1992/Disertacija.pdf
http://nardus.mpn.gov.rs/bitstream/id/1992/Disertacija.pdf